ask="5.75"
ask_size="200"
average_daily_volume="139226"
bid="3.84"
bid_size="100"
book_value="2.54"
change="-0.02"
change_from_200_day_moving_average="-1.27"
change_from_50_day_moving_average="0.30"
change_from_52_week_high="-7.11"
change_From_52_week_low="0.72"
change_in_percent="-0.44%"
close="4.48"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.51"
ebitda="-74.76M"
eps_estimate_current_year="-1.08"
eps_estimate_next_quarter="-0.30"
eps_estimate_next_year="-1.17"
ex_dividend_date="N/A"
float_shares="23413000"
high="4.56"
high_52_weeks="11.59"
last_trade_date="2/2/2017"
last_trade_price="4.48"
last_trade_size="604"
last_trade_time="4:00pm"
low="4.43"
low_52_weeks="3.76"
market_capitalization="317.12M"
moving_average_200_day="5.75"
moving_average_50_day="4.18"
name="Adaptimmune Therapeutics plc"
notes="N/A"
one_year_target_price="15.20"
open="4.45"
pe_ratio="N/A"
peg_ratio="0.30"
percent_change_from_200_day_moving_average="-22.12%"
percent_change_from_50_day_moving_average="+7.21%"
percent_change_from_52_week_high="-61.34%"
percent_change_from_52_week_low="+19.15%"
previous_close="4.50"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.77"
price_per_sales="33.45"
revenue="9.52M"
shares_outstanding="70785000"
short_ratio="2.34"
stock_exchange="NMS"
symbol="ADAP"
volume="36591"
weeks_range_52="3.76 - 11.59"
